Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Coya Therapeutics (COYA) Equity Ratio (2022 - 2025)

Coya Therapeutics' Equity Ratio history spans 4 years, with the latest figure at 0.85 for Q3 2025.

  • For Q3 2025, Equity Ratio fell 5.43% year-over-year to 0.85; the TTM value through Sep 2025 reached 0.85, down 5.43%, while the annual FY2024 figure was 0.89, 3.34% up from the prior year.
  • Equity Ratio for Q3 2025 was 0.85 at Coya Therapeutics, up from 0.85 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.93 in Q1 2023 and bottomed at 1.0 in Q4 2022.
  • The 4-year median for Equity Ratio is 0.87 (2025), against an average of 0.72.
  • The largest annual shift saw Equity Ratio surged 186.38% in 2023 before it fell 6.58% in 2024.
  • A 4-year view of Equity Ratio shows it stood at 1.0 in 2022, then soared by 186.38% to 0.86 in 2023, then increased by 3.34% to 0.89 in 2024, then dropped by 4.59% to 0.85 in 2025.
  • Per Business Quant, the three most recent readings for COYA's Equity Ratio are 0.85 (Q3 2025), 0.85 (Q2 2025), and 0.87 (Q1 2025).